HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection

RecruitingOBSERVATIONAL
Enrollment

8,000

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Hepatitis D
Interventions
OTHER

HDV screening

1\. Analyze the rate of HDV-testing and evaluate the prevalence of HDV-infection by testing.

Trial Locations (1)

53127

RECRUITING

University Hospital Bonn, Bonn

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Swiss HIV Cohort Study

NETWORK

collaborator

ICONA Cohort

UNKNOWN

collaborator

Amsterdam UMC

OTHER

collaborator

Royal Free Hospital NHS Foundation Trust

OTHER

collaborator

King's College London

OTHER

collaborator

University Hospital of Cologne

OTHER

collaborator

Goethe University

OTHER

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

collaborator

University Hospital, Essen

OTHER

collaborator

ICH Hamburg

UNKNOWN

collaborator

Praxiszentrum Hohenstaufenring Köln

UNKNOWN

collaborator

Sorbonne University

OTHER

collaborator

Henri Mondor University Hospital

OTHER

collaborator

Hospital Universitario Infanta Leonor

OTHER

collaborator

Hospital General Universitario Gregorio Marañon

OTHER

collaborator

GEPCOI (Portuguese Group of Coinfection)

UNKNOWN

lead

University Hospital, Bonn

OTHER